ProfileGDS4718 / 1555350_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 39% 42% 36% 44% 38% 50% 45% 50% 40% 43% 45% 44% 43% 45% 51% 39% 40% 44% 55% 39% 54% 44% 41% 46% 42% 44% 38% 45% 37% 47% 43% 48% 47% 46% 44% 51% 41% 43% 42% 37% 44% 45% 40% 45% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9283339
GSM549102patient 115, normal, homogenized [OPG study]5.1066942
GSM549104patient 119, normal, homogenized [OPG study]4.7890336
GSM549108patient 138, normal, homogenized [OPG study]5.2652444
GSM549119patient 077, normal, homogenized [OPG study]4.9181638
GSM549133patient 032, cancer, homogenized [OPG study]5.4747150
GSM549139patient 042, cancer, homogenized [OPG study]5.2341345
GSM549099patient 107, normal, homogenized [OPG study]5.5265950
GSM549109patient 139, normal, homogenized [OPG study]5.0294440
GSM549110patient 046, normal, homogenized [OPG study]5.1283943
GSM549114patient 063, normal, homogenized [OPG study]5.1753145
GSM549122patient 082, normal, homogenized [OPG study]5.1697644
GSM549134patient 033, cancer, homogenized [OPG study]5.1087743
GSM549136patient 036, cancer, homogenized [OPG study]5.1630145
GSM549140patient 044, cancer, homogenized [OPG study]5.5156151
GSM549111patient 047, normal, homogenized [OPG study]4.9191839
GSM549113patient 057, normal, homogenized [OPG study]4.945140
GSM549132patient 031, cancer, homogenized [OPG study]5.1744744
GSM549137patient 038, cancer, homogenized [OPG study]5.8125955
GSM549142patient 047, cancer, homogenized [OPG study]5.0727239
GSM549100patient 110, normal, homogenized [OPG study]5.7552554
GSM549107patient 135, normal, homogenized [OPG study]5.1745644
GSM549115patient 068, normal, homogenized [OPG study]4.9923841
GSM549116patient 072, normal, homogenized [OPG study]5.274646
GSM549120patient 078, normal, homogenized [OPG study]5.099442
GSM549131patient 030, cancer, homogenized [OPG study]5.1134544
GSM549118patient 074, normal, homogenized [OPG study]4.8732338
GSM549129patient 027, cancer, homogenized [OPG study]5.2774845
GSM549123patient 088, normal, homogenized [OPG study]4.8258537
GSM549124patient 006, cancer, homogenized [OPG study]5.3944647
GSM549126patient 015, cancer, homogenized [OPG study]5.1374743
GSM549128patient 025, cancer, homogenized [OPG study]5.3939748
GSM549103patient 117, normal, homogenized [OPG study]5.4312347
GSM549117patient 073, normal, homogenized [OPG study]5.2802246
GSM549138patient 041, cancer, homogenized [OPG study]5.1879244
GSM549141patient 045, cancer, homogenized [OPG study]5.5222251
GSM549130patient 028, cancer, homogenized [OPG study]5.0304241
GSM549101patient 111, normal, homogenized [OPG study]5.1611243
GSM549105patient 128, normal, homogenized [OPG study]5.1274442
GSM549106patient 134, normal, homogenized [OPG study]4.8059437
GSM549112patient 048, normal, homogenized [OPG study]5.1740144
GSM549125patient 011, cancer, homogenized [OPG study]5.2308645
GSM549127patient 024, cancer, homogenized [OPG study]4.9708340
GSM549135patient 035, cancer, homogenized [OPG study]5.2268745